Vesalius Cardiovascular Reaches a New and Advanced Pre-Clinical Milestone
In a first-of-its-kind study, Vesalius proves that their catheter-based anchoring to the papillary muscle is safe and durable.
Vesalius Cardiovascular Announces the Completion of a Successful Chronic Animal Study
VANCOUVER, British Columbia, January 21, 2020 (Newswire.com) Vesalius Cardiovascular Inc. (VCI), a pre-clinical stage medical device company developing novel percutaneous therapies for the treatment of mitral regurgitation, today announced the successful completion of their first 30-day chronic animal study using their mitral valve repair device. The predetermined endpoints of the study were the absence of […]